eMed
Digital health for weight management
CORE INFO
eMed is a digital health company that offers a comprehensive mobile platform for managing GLP-1 medications, targeting weight management and chronic care for obesity and type 2 diabetes. Their services are designed for employers and employees, providing accessible and effective healthcare solutions.
- eMed raised $200 million in a Series A funding round, achieving a valuation of over $2 billion.reuters.com
- The company has partnered with Aon, Thrive Global, and CVS Health to enhance lifestyle support and provide scalable GLP-1 access for employers.emed.com
- eMed's GLP-1 program boasts an adherence rate of over 90%, with members experiencing an average weight loss of 25 pounds.emed.com
WHY WE WOULD WORK AT EMED
Empower Health Outcomes
Join a mission-driven team focused on improving healthcare outcomes through innovative GLP-1 management solutions, helping users achieve significant weight loss and better health.
Innovative Technology
Work with cutting-edge technology that integrates screening, prescribing, and lifestyle management into a seamless mobile platform, revolutionizing chronic care for obesity and diabetes.
Collaborative Culture
Be part of a compassionate and adaptable team that values collaboration, ensuring every voice is heard and every idea is considered in shaping the future of digital health.
Competitive Compensation
Benefit from a robust compensation package supported by $200M in Series A funding, reflecting the company's commitment to attracting top talent in the digital health space.
Proven Success Metrics
Join a company with a GLP-1 program adherence rate exceeding 90% and an average weight loss of 25 pounds per member, showcasing the real impact of your work.
Diverse Partnerships
Collaborate with industry leaders like Aon and CVS Health, enhancing your professional network while contributing to scalable, cost-effective healthcare solutions for employers.
MARKET AND TRACTION
KEY METRICS
✦ KEY METRICNOTABLE CUSTOMERS
GROWTH TACTICS
TOTAL ADDRESSABLE MARKET
COMPETITIVE ADVANTAGE
PRODUCT AND TECH
GLP-1 Management Program
eMed's GLP-1 Management Program integrates screening, prescribing, direct medication sourcing, adherence monitoring, lifestyle management, and biomarker testing into a seamless mobile platform, aiming to enhance healthcare outcomes for weight management and chronic care.
Mobile Health Platform
The mobile platform provides users with 24/7 on-demand access to verified care, facilitating easy management of GLP-1 medications and supporting lifestyle changes for sustainable weight management.
Partnership Ecosystem
eMed collaborates with organizations like Aon, Thrive Global, and CVS Health to deliver comprehensive behavior-change and lifestyle support, enabling scalable and cost-effective access to GLP-1 medications for employers.
Adherence Monitoring System
With an adherence rate exceeding 90%, eMed's monitoring system ensures that users stay on track with their GLP-1 treatment plans, significantly improving health outcomes and reducing risks associated with obesity and type 2 diabetes.
Biomarker Testing Integration
The incorporation of biomarker testing within the GLP-1 Management Program allows for personalized health assessments, helping to tailor treatment plans and monitor progress effectively.